Top Markets
Coin of the day
Guangzhou Innogen Pharmaceutl Grp Co Ltd Guangzhou Innogen Pharmaceutl Grp Co Ltd

Guangzhou Innogen Pharmaceutl Grp Co Ltd

2591
Rank in Stocks #18331
Guangzhou Innogen Pharmaceutical Group Co Ltd operates as a China-based... Guangzhou Innogen Pharmaceutical Group Co Ltd operates as a China-based investment holding firm with a core mission to research, develop, and bring to market medicinal products. The company specializes in producing innovative, human-compatible, and extended-duration GLP-1 receptor agonists, specifically targeting the treatment of diabetes and other metabolic conditions.
Share Price
$0.44518328
Market Cap
$203.37M
Change (1 day)
-2.11%
Change (1 year)
-91.76%
Country
CN
Trade Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591)

Category

P/B ratio for Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591)
P/B ratio as of 2026 TTM: 0
According to Guangzhou Innogen Pharmaceutl Grp Co Ltd latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Guangzhou Innogen Pharmaceutl Grp Co Ltd from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.828 -
US
7.5116 -
NL
8.2199 -
US
3.9942 -
AU
- -
CH